Grace Therapeutics, Inc. (GRCE)
Pharmaceutical Preparations
Latest Price
$2.29
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.79
P/B Ratio
0.82
Institutional Ownership
25.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cerity Partners LLC | 849.1K | $1.0M | 5.22% | -- | 2026-06-30 |
| Eversept Partners, LP | 772.9K | $1.0M | 4.75% | +16.3K | 2026-06-30 |
| BANK OF AMERICA CORP /DE/ | 494.7K | $1.0M | 3.04% | -25 | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 411.7K | -- | 2.53% | +10.1K | 2026-06-30 |
| CITADEL ADVISORS LLC | 402.2K | -- | 2.47% | +303.5K | 2026-06-30 |
| Stonepine Capital Management, LLC | 294.6K | -- | 1.81% | +83.5K | 2026-06-30 |
| Maven Securities LTD | 200.0K | -- | 1.23% | -- | 2026-06-30 |
| JANE STREET GROUP, LLC | 161.5K | -- | 0.99% | -5.6K | 2026-06-30 |
| Birchview Capital, LP | 120.0K | -- | 0.74% | +70.0K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 96.9K | -- | 0.60% | -- | 2026-06-30 |